Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.

Tchivileva IE, Lim PF, Smith SB, Slade GD, Diatchenko L, McLean SA, Maixner W.

Pharmacogenet Genomics. 2010 Apr;20(4):239-48. doi: 10.1097/FPC.0b013e328337f9ab.

2.

Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.

Orrey DC, Halawa OI, Bortsov AV, Shupp JW, Jones SW, Haith LR, Hoskins JM, Jordan MH, Bangdiwala SI, Roane BR, Platts-Mills TF, Holmes JH, Hwang J, Cairns BA, McLean SA.

Clin J Pain. 2015 Jan;31(1):21-9. doi: 10.1097/AJP.0000000000000086.

3.

COMT Diplotype Amplifies Effect of Stress on Risk of Temporomandibular Pain.

Slade GD, Sanders AE, Ohrbach R, Bair E, Maixner W, Greenspan JD, Fillingim RB, Smith S, Diatchenko L.

J Dent Res. 2015 Sep;94(9):1187-95. doi: 10.1177/0022034515595043. Epub 2015 Jul 21.

PMID:
26198390
4.

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.

Rakvåg TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P.

Mol Pain. 2008 Dec 18;4:64. doi: 10.1186/1744-8069-4-64.

5.

Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder.

Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W.

J Pain. 2009 May;10(5):542-52. doi: 10.1016/j.jpain.2008.12.006.

6.

The effect of catechol-O-methyltransferase polymorphisms on pain is modified by depressive symptoms.

Schwahn C, Grabe HJ, Meyer zu Schwabedissen H, Teumer A, Schmidt CO, Brinkman C, Kocher T, Nauck M, Völzke H, Biffar R, Bernhardt O.

Eur J Pain. 2012 Jul;16(6):878-89. doi: 10.1002/j.1532-2149.2011.00067.x. Epub 2011 Dec 19.

PMID:
22337325
7.

Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W.

Hum Mol Genet. 2005 Jan 1;14(1):135-43. Epub 2004 Nov 10.

8.

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W.

Pain. 2006 Dec 5;125(3):216-24. Epub 2006 Jul 11.

PMID:
16837133
9.

Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.

Goncalves DA, Camparis CM, Speciali JG, Castanharo SM, Ujikawa LT, Lipton RB, Bigal ME.

J Orofac Pain. 2013 Fall;27(4):325-35. doi: 10.11607/jop.1096.

PMID:
24171182
10.

Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Nackley AG, Shabalina SA, Lambert JE, Conrad MS, Gibson DG, Spiridonov AN, Satterfield SK, Diatchenko L.

PLoS One. 2009;4(4):e5237. doi: 10.1371/journal.pone.0005237. Epub 2009 Apr 13.

11.

Influence of psychological factors on risk of temporomandibular disorders.

Slade GD, Diatchenko L, Bhalang K, Sigurdsson A, Fillingim RB, Belfer I, Max MB, Goldman D, Maixner W.

J Dent Res. 2007 Nov;86(11):1120-5.

PMID:
17959908
12.
13.

Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene.

Martínez-Jauand M, Sitges C, Rodríguez V, Picornell A, Ramon M, Buskila D, Montoya P.

Eur J Pain. 2013 Jan;17(1):16-27. doi: 10.1002/j.1532-2149.2012.00153.x. Epub 2012 Apr 24.

PMID:
22528689
14.

Variation in the COMT gene: implications for pain perception and pain treatment.

Andersen S, Skorpen F.

Pharmacogenomics. 2009 Apr;10(4):669-84. doi: 10.2217/pgs.09.13. Review.

PMID:
19374521
15.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
16.

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.

Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F.

Pain. 2005 Jul;116(1-2):73-8.

PMID:
15927391
17.

The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorder.

Fijal B, Perlis RH, Heinloth AN, Houston JP.

J Pain. 2010 Sep;11(9):910-5, 915.e1-9. doi: 10.1016/j.jpain.2009.12.016.

PMID:
20627703
18.

Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.

Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W.

Pain. 2007 Apr;128(3):199-208. Epub 2006 Nov 7.

19.

Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.

Smith SB, Reenilä I, Männistö PT, Slade GD, Maixner W, Diatchenko L, Nackley AG.

Pain. 2014 Nov;155(11):2390-9. doi: 10.1016/j.pain.2014.09.009. Epub 2014 Sep 16.

20.

Pain modality- and sex-specific effects of COMT genetic functional variants.

Belfer I, Segall SK, Lariviere WR, Smith SB, Dai F, Slade GD, Rashid NU, Mogil JS, Campbell CM, Edwards RR, Liu Q, Bair E, Maixner W, Diatchenko L.

Pain. 2013 Aug;154(8):1368-76. doi: 10.1016/j.pain.2013.04.028. Epub 2013 Apr 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk